Crypto firm CrossTower to celebrate Diwali at World Trade Center in NY
Darpan News Desk IANS, 03 Nov, 2021 08:11 PM
Global crypto exchange company CrossTower announced its partnership with the South Asian Engagement Forum to celebrate Diwali at the iconic World Trade Center in New York City.
For the first time in history, three-day Diwali celebrations will be held from November 2-4, showcasing a spectacular digital mural on the WTC podium and fireworks over the Hudson River.
"CrossTower is privileged to be a partner of the first ever All-American Diwali celebration, especially so soon after our expansion into India. Given that there are 2.7 million Indians in the US, this event combines the American tradition with the festival and has brought together two biggest democratic countries, the US and India, to celebrate one of the biggest festivals," said Kapil Rathi, Chief Executive Officer and Co-Founder of CrossTower, in a statement.
This event combines the American tradition of viewing fireworks over the Hudson River with the festival of lights.
A fireworks display will take place on the Hudson and be available via livestream on Diwali Eve on November 3, to inspire Indian Americans to engage with their neighbours, colleagues, and friends from a variety of backgrounds in engaging conversations about Diwali.
"There is no better symbol of the triumph of resiliency than the World Trade Center and we are very fortunate to be able to bring this message to all,"said Rahul Walia, Indian American founding trustee of the South Asian Engagement Foundation.
The lawsuit takes aim at the leaders of the Hindu organization known as Bochasanwasi Akshar Purushottam Swaminarayan Sanstha, or BAPS, for human trafficking and exploitation of workers through low wages.
Tensions simmering in Jerusalem in recent days have taken deadly turn as militants in the Gaza Strip and Israel exchanged attacks, with at least 20 people killed, according to officials.
Many Indian Americans are wracked with guilt over emerging from more than a year of isolation as relatives overseas struggle to find vaccines, hospital beds and, fatefully, their breath.
Many of the 64 people affected either fainted or reported dizziness. Some got nauseous or vomited, and a few had racing hearts, chest pain or other symptoms.
In a statement Friday, the two pharmaceuticals said their submission to the European Medicines Agency is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective.
